← Leaderboards
Oren Josh Becher
Duke University
$4,175,030
Attributed
$5,522,639
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $686.1K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,522,639 · 5
By mechanism
R01$4,427,415 · 2
K02$671,406 · 1
R21$420,750 · 1
P41$3,068 · 1
Top collaborators
- Dolores Hambardzumyan5 shared
Most similar at Duke University
Same institution · by research overlap
- Michael Barry Kastan$65,974,699
- David M. Ashley$7,073,119
- Zachary Reitman$907,521
- Mary Min-Chin Lee$2,922,536
- Joseph A. Goldman$173,914
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelTumorChildhood Brain NeoplasmMutationCellsHistonesChildIn VitroFoundationsBrain StemGenesGenetically Engineered MouseGeneticGliomaDiffuse Intrinsic Pontine GliomaAffectIn VivoMolecularComplexPolycombClinical TrialsMalignant Neoplasm Of BrainGliomagenesisEffective Therapy
Grant awards (20)
The role of Myeloid cells in pediatric-high grade gliomas$594,958
R01 · FY2025 · CA
The role of Myeloid cells in pediatric-high grade gliomas$87,493
R01 · FY2025 · CA
The role of Myeloid cells in pediatric-high grade gliomas$651,334
R01 · FY2024 · CA
The role of Myeloid cells in pediatric-high grade gliomas$675,370
R01 · FY2023 · CA
The role of Myeloid cells in pediatric-high grade gliomas$686,064
R01 · FY2022 · CA
Role of the K27M histone mutation in midline gliomas initiated in oligodendrocyte progenitors$191,250
R21 · FY2021 · NS · contact PI
Functional Dissection of the K27M Histone Mutation In Gliomagenesis$176,858
R01 · FY2021 · CA · contact PI
FUNCTIONAL DISSECTION OF THE K27M HISTONE MUTATION IN GLIOMAGENESIS$173,130
R01 · FY2021 · CA · contact PI
FUNCTIONAL DISSECTION OF THE K27M HISTONE MUTATION IN GLIOMAGENESIS$349,988
R01 · FY2020 · CA · contact PI
Role of the K27M histone mutation in midline gliomas initiated in oligodendrocyte progenitors$229,500
R21 · FY2020 · NS · contact PI
FUNCTIONAL DISSECTION OF THE K27M HISTONE MUTATION IN GLIOMAGENESIS$250,471
R01 · FY2019 · CA · contact PI
Functional Dissection of the K27M Histone Mutation In Gliomagenesis$86,889
R01 · FY2019 · CA · contact PI
Functional Dissection of the K27M Histone Mutation In Gliomagenesis$334,865
R01 · FY2018 · CA · contact PI
Functional Dissection of the K27M Histone Mutation in Vivo$140,956
K02 · FY2017 · NS · contact PI
Functional Dissection of the K27M Histone Mutation In Gliomagenesis$359,995
R01 · FY2016 · CA · contact PI
Functional Dissection of the K27M Histone Mutation in Vivo$96,555
K02 · FY2016 · NS · contact PI
Functional Dissection of the K27M Histone Mutation in Vivo$44,081
K02 · FY2016 · NS · contact PI
Functional Dissection of the K27M Histone Mutation in Vivo$194,907
K02 · FY2015 · NS · contact PI
Functional Dissection of the K27M Histone Mutation in Vivo$194,907
K02 · FY2014 · NS · contact PI
EVALUATE CDK4/6 INHIBITOR PD0332991 ALONE/WITH RADIATION IN DIPG MOUSE MODEL$3,068
P41 · FY2011 · RR · contact PI